An update on preclinical pregnancy models of Zika virus infection for drug and vaccine discovery.
Cecilia BenazzatoFabiele Baldino RussoPatricia Cristina Baleeiro Beltrão-BragaPublished in: Expert opinion on drug discovery (2021)
The discovery of drugs against ZIKV infection represents an urgent necessity, and until now, no effective drug that can prevent the effects of vertical transmission has been tested in humans. Even after six years of the ZIKV outbreak in Brazil, no drugs or vaccines have been approved for use in humans. In part, this failure could be related to the lack of translatability from available preclinical models to humans.